Our analysis reveals an inverse correlation between UCA1 and FAM171A2 expression, suggesting that UCA1-mediated oncogenic signaling may suppress FAM171A2-associated regulatory pathways, thereby enhancing drug resistance mechanisms in ovarian cancer cells. The gene discussed is UCA1; the disease is ovarian cancer.